XML 43 R29.htm IDEA: XBRL DOCUMENT v3.25.2

Segment and Geographic Data (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

Segment Results
	Three Months				Six Months
	2025		2024		2025		2024
MedSurg and Neurotechnology	$3,771		$3,215		$7,282		$6,312
Orthopaedics	2,251		2,207		4,606		4,353
Net sales	$6,022		$5,422		$11,888		$10,665
MedSurg and Neurotechnology	$1,414		$1,287		$2,736		$2,525
Orthopaedics	599		576		1,228		1,167
Cost of sales	$2,013		$1,863		$3,964		$3,692
MedSurg and Neurotechnology	$246		$194		$471		$389
Orthopaedics	127		136		267		270
Segment research, development and engineering expenses	$373		$330		$738		$659
MedSurg and Neurotechnology	$984		$775		$1,921		$1,538
Orthopaedics	743		756		1,590		1,507
Segment selling, general and administrative expenses	$1,727		$1,531		$3,511		$3,045
MedSurg and Neurotechnology	$58		$56		$115		$110
Orthopaedics	104		105		202		213
Segment depreciation and amortization	$162		$161		$317		$323
Corporate and Other	$40		$38		$79		$78
Amortization of intangible assets	187		155		354		308
Total depreciation and amortization	$389		$354		$750		$709
MedSurg and Neurotechnology	$1,069		$903		$2,039		$1,750
Orthopaedics	678		634		1,319		1,196
Segment operating income	$1,747		$1,537		$3,358		$2,946
Items not allocated to segments:
Corporate and Other	$(202)		$(203)		$(469)		$(466)
Inventory stepped up to fair value	(65)		(9)		(99)		(9)
Acquisition and integration-related charges	(78)		(14)		(263)		(1)
Amortization of intangible assets	(187)		(155)		(354)		(308)
Structural optimization and other special charges	(11)		(59)		(52)		(70)
Goodwill and other impairments	(55)		(16)		(90)		(19)
Medical device regulation	(7)		(15)		(19)		(28)
Recall-related matters	(22)		(17)		(55)		(22)
Regulatory and legal matters	(7)		2		(7)		—
Consolidated operating income	$1,113		$1,051		$1,950		$2,023

Segment Assets
	June 30		December 31
	2025		2024
Assets:
MedSurg and Neurotechnology	$26,909		$23,115
Orthopaedics	17,865		18,507
Total segment assets	$44,774		$41,622
Corporate and Other	1,557		1,349
Total assets	$46,331		$42,971

Sales and Other Financial Information by Business Segment

Segment Capital Spending	Six Months
	2025		2024
Purchases of property, plant and equipment:
MedSurg and Neurotechnology	$95		$83
Orthopaedics	101		111
Total segment purchases of property, plant and equipment	$196		$194
Corporate and Other	110		125
Total purchases of property, plant and equipment	$306		$319

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration